Email Updates

You are here

Home»Media

AVAC in the News

  • African Studies Explore Reasons To Start, Stick With or Stop PrEP

    This year's HIV Research for Prevention (HIVR4P) virtual conference featured a large number of sessions examining PrEP usage and discontinuation rates among a variety of users, especially in Africa. Many of the presentations looked at factors that worked as incentives to keep taking PrEP. There is interest in this because, despite higher initiation rates in a larger number of countries than ever before, the retention rates (also called persistence rates) of people in PrEP programmes in the region remain very low.

    February 8, 2021
    PrEP
    aidsmap

  • HIV Science Has Advanced but Policies-Programmes Have Been Slow to #endAIDS

    HIV science has advanced but policies and programmes have been slow to respond towards ending AIDS, said Mitchell Warren, co-chair of the global conference on HIV Research for Prevention (HIVR4P) and Executive Director of AVAC.

    February 7, 2021
    Microbicides, Multipurpose Prevention Technologies, PrEP, Treatment
    CNS

  • Funding for COVID-19 Overshadows HIV/TB Research Expense

    Global funding for COVID-19 vaccine development has exceeded 10 times in less than a year the amount allocated for HIV and TB research and development in 11 years.

    February 6, 2021
    General
    The International News

  • Africa’s Success in Rapidly Rolling Out HIV Prevention Measure, PrEP

    When Wasiu spoke to Devex in 2018 about his HIV-positive status and the statuses of his three wives, the two living with him in Nigeria had tested positive for HIV while the one in the United States was HIV-negative due to distance and her ability to access pre-exposure prophylaxis, or PrEP.

    February 5, 2021
    PrEP
    Devex

  • African Nations Lead the World in Offering PrEP HIV Prevention Drug

    Nearly 1 million people are now taking pre-exposure prophylaxis (PrEP), medicine that can slash the risk of HIV infections. While early use of the drug was mostly limited to Western nations, the number of users in sub-Saharan Africa (SSA) has now drastically increased, accounting for more than half of the world’s PrEP users.

    February 2, 2021
    PrEP
    New Scientist

  • Nearly a Million Have Started Taking PrEP Worldwide – Only a Third of UNAIDS’ 2020 Target

    Despite the incredible efficacy of oral pre-exposure prophylaxis (PrEP) and 78 countries currently offering PrEP in some form, its effectiveness at reducing HIV incidence in the real world has been dependent on far-reaching factors that go beyond how well PrEP is able to prevent HIV acquisition at a cellular level: political leadership, quality health services and funding.

    February 1, 2021
    PrEP
    aidsmap

  • Important Advances in HIV Prevention Unveiled: New PrEP Formulas & Broadly Neutralizing Antibodies

    While global attention has fixated on the coronavirus, the forty-year long fight against HIV, which has claimed 33 million lives, is seeing new breakthroughs in preventive tools. New discoveries of “broadly neutralizing antibodies” as well as novel regimens of pre-exposure prophylaxis (PrEP), could strengthen the world’s toolbox to prevent the disease, announced the International AIDS Society (IAS) at the opening of the 4th HIV Research for Prevention Conference.

    January 27, 2021
    Antibody Related Research, PrEP
    Health Policy Watch

  • A Pill, a Ring or a Jab: The future of HIV prevention is choice

    South Africa is ahead of local targets in rolling out the HIV prevention pill. Meanwhile, options for HIV prevention are expanding — though the devil is in the detail of getting medicines to people in a way that works for them.

    January 27, 2021
    PrEP
    Daily Maverick

  • AMPing up HIV Prevention: An inside look at how the immune system fights off the virus

    New pivotal research, the first of its kind to announce results, builds on ideas from vaccination and tests a new idea: whether special antibodies — the type that can help someone fight off multiple forms of the virus — can be used to prevent HIV infection.

    January 27, 2021
    Antibody Related Research
    Bhekisisa

  • HIV PrEP Uptake Increases Sixfold in 4 Years, Still Falls Sort of Global Goals

    HIV PrEP uptake has increased sixfold globally in the last 4 years but remains short of the UNAIDS target of 3 million users, according to data reported during the HIV Research for Prevention virtual conference.

    January 26, 2021
    PrEP
    Healio

Pages